Background. Primary cytoreductive surgery (PDS) followed by platinum-based chemotherapy is the cornerstone of treatment and the absence of residual tumor after PDS is universally considered the most important prognostic factor. The aim of the present analysis was to evaluate trend and predictors of 30-day mortality in patients undergoing primary cytoreduction for ovarian cancer. Methods. Literature was searched for records reporting 30-day mortality after PDS. All cohorts were rated for quality. Simple and multiple Poisson regression models were used to quantify the association between 30-day mortality and the following: overall or severe complications, proportion of patients with stage IV disease, median age, year of publication, and weighted surgical complexity index. Using the multiple regression model, we calculated the risk of perioperative mortality at different levels for statistically significant covariates of interest. Results. Simple regression identified median age and proportion of patients with stage IV disease as statistically significant predictors of 30-day mortality. When included in the multiple Poisson regression model, both remained statistically significant, with an incidence rate ratio of 1.087 for median age and 1.017 for stage IV disease. Disease stage was a strong predictor, with the risk estimated to increase from 2.8% (95% confidence interval 2.02-3.66) for stage III to 16.1% (95% confidence interval 6.18-25.93) for stage IV, for a cohort with a median age of 65 years. Conclusions. Metaregression demonstrated that increased age and advanced clinical stage were independently associated with an increased risk of mortality, and the combined effects of both factors greatly increased the risk.
1
Cytoreductive surgery followed by platinum-based chemotherapy is the cornerstone of treatment for patients with advanced disease stage. Absence of macroscopic residual tumor after cytoreductive surgery is universally considered the most important prognostic factor. 2 Maximal surgical effort has been associated with increased morbidity, and different risk-adjusted prediction models of morbidity have been proposed. [3] [4] [5] However, only a few reports have evaluated factors associated with postoperative mortality reported as the primary outcome, making it difficult to draw definitive conclusions on predictors of mortality.
Analysis of factors associated with postoperative mortality could help to predict the risk of perioperative mortality and to identify those subgroups of patients who might benefit from alternative treatment approaches.
The aims of the present analysis were to evaluate the mortality rate and its trends over the last three decades in patients who underwent primary cytoreduction for ovarian cancer, and to analyze the main factors associated with perioperative mortality.
METHODS

Search Strategy
In May 2015 three authors (VDD, AC, and IP) performed a computerized search of Medline, CINAHL, and Web of Science for all English-language studies containing mortality data for patients underwent primary cytoreductive surgery (PDS) for ovarian cancer. The search strategy combined the following medical subject headings and keywords: (ovarian cancer OR ovarian neoplasms OR cytoreductive surgery OR postoperative mortality OR surgical debulking OR surgical related deaths). The abstracts and, where appropriate, full text of articles and cross-referenced studies identified from retrieved articles were screened for pertinent information.
Selection of Studies
Key inclusion criteria were reported 30-day mortality for a group of C30 patients undergoing PDS for ovarian/tubal/peritoneal cancer. Studies overlapping with other studies as indicated by the corresponding author were excluded, as were studies of patients submitted to neoadjuvant chemotherapy. If a study reported data on neoadjuvant chemotherapy versus primary debulking surgery, only data on primary debulking were considered. For each eligible study cohort, the following information was recorded: age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, stage of disease according to International Federation of Gynecology and Obstetrics (FIGO) staging system, surgery-related results, and postoperative outcomes.
Methodologic Quality Assessment
Three investigators carried out data extraction and quality assessment from all the retrieved studies based on full-text articles. Discrepancies between the investigators were resolved by consensus.
A quality score was used to evaluate whether any studies were useful for the purpose of our analysis (see Appendix).
Statistical Analyses
The primary outcome of interest was postoperative mortality. Potential predictors included the following: any type and severe complications (expressed as percentage of patients), year of study publication, accrual interval (in years), median age of the study cohort, BMI of the study cohort, mean number of procedures, weighted complexity index, highest procedure complexity (see Appendix), and percentage of patients with stage IV disease. Simple Poisson regression models were used to quantify the association of each of the potential predictors with each of the outcomes. The estimated associations were expressed as incidence rate ratios (IRRs), demonstrating the changes in the incidence rate (i.e., the rate at which events occurs, in our case number of deaths or complications in N-operated patients) associated with changes in the predictor. Each estimated association was also plotted along with the observations from each study, weighted for their respective size, a common graphical output for metaregression analyses. Although multiple Poisson regression models can be problematic when a modest number of studies is meta-analyzed (usually \60), we decided to perform such analyses if any statistically significant predictors were identified in the simple models to assess the independent contribution of these variables to the outcome. The delta method was used to obtain the appropriate standard errors of any smooth function of the fitted model parameters. We used the margins command in Stata to calculate estimates for adjusted mortality incidence rates at various different levels for participant's median age (55, 65, 70 and 75) and percentage of FIGO stage IV (0 and 100%). An alpha level of 5% was used throughout and we report 95% Confidence Intervals for all estimates. Stata 13.1 (StataCorp, College Station, TX) was used for all analyses.
RESULTS
Study Characteristics
A total of 1372 citations were initially screened. After further selection, 46 studies (3.3%), encompassing 18,579 patients met all of the inclusion criteria. (33, 38 , and 50 days), and in 10 studies it was not reported as a value. The characteristics of the studies are summarized in Table 1 .
Perioperative Mortality
The total number of deaths across all cohorts (n = 46) was 807. Considering all cohorts, the weighted mean perioperative mortality was 4.64% (95% confidence interval [CI] 4.58-4.69). Twenty (43.5%) of 46 studies reported the causes of death in detail. The principal cause of death was sepsis in 22.6%, followed by respiratory failure in 14.8% and pulmonary embolism in 9.6%. Multiorgan failure, defined as the presence of two or more organ failures other than cardiovascular, was described in 5.2% as the first cause of death. The main causes of death are reported in Table 2 . The day of event was reported only in 18 patients; in this group, the median day of postoperative mortality was day 12 (range 2-30).
Simple Poisson Regression Models of Predictor Variables
The results of simple Poisson regression analyses are shown in Table 3 . Figure 1a shows log mortality rate plotted against year of publication for all 46 patient cohorts. There was an inverse correlation between year of publication and mortality rate. However, this trend was not statistically significant (p = 0.704). Each year of publication was associated with an estimated 1.1% decrease in the incidence rate for mortality (IRR 0.989; 95% CI 0.936-1.046). We did not observe a statistically significant association between the year of publication and either the proportion of patients affected by any type of complication or the proportion of patients affected by a severe complication.
Year of Publication and Accrual Interval
Median Age
Median age was not available for six patient cohorts. Analysis of median age versus mortality rate of the 40 patient cohorts is shown in Fig. 1b . The mean weighted median age was 65.9 years. Cohorts with a median age of\65 years had a mortality rate of 2.6% compared to 7.64% for cohorts with a median age of[65 years. Each 1-year increase in median age was associated with an estimated 10.9% increase in the mortality rate (IRR 1.109; 95% CI 1.069-1.150). We did not observe a statistically significant association between median age and the proportion of patients affected by any type of complication or the proportion of patients affected by a severe complication.
FIGO Stage IV
FIGO stage was available for 43 patient cohorts. The weighted mean proportion of patients with FIGO stage IV disease per cohort was 24.1% (range 0-100%). Simple Poisson regression models revealed a significant relationship between proportion of stage IV disease and incidence rate for mortality (Fig. 1c) . Each 1% increase in the proportion of patients with stage IV disease was associated with a 1.7% increase in the incidence rate of mortality (IRR 1.017; 95% CI 1.008-1.028 Number of Surgical Procedures, Weighted Surgical Complexity, and Highest Procedure Complexity
The number of surgical procedures, weighted surgical complexity index, and highest procedure complexity were computable in 26 cohorts; for all these cohorts, the weighted mean value of number of surgical procedures, weighted surgical complexity index, and highest procedure complexity index were, respectively, 3.33 (95% CI 3.27-3.39), 3.81 (95% CI 3.73-3.90), and 2.50 (95% CI 2.42-2.58). We did not observe a statistically significant association between the weighted mean value of these parameters and the incidence rate of mortality, although an inverse trend was observed.
Rate of Overall and Severe Complications
Overall complication rate and severe complication rate was reported, respectively, in 30 (65.2%) and 11 (23.9%) cohorts. The weighted mean overall and severe complication rates were 23.81% (95% CI 23.60-24.02) and 9.51% (95% CI 9.34-9.68), respectively. We did not observe a statistically significant association between the overall complication rate and incidence rate of mortality, although there was a significant relationship between the proportion of severe complications and the incidence rate for mortality (IRR 1.057; 95% CI 1.025-1.089).
ASA Score, BMI, and Albumin Level ASA score was reported for only ten patient cohorts. The weighted mean percentage of patients with an ASA score of C3 per cohort was 48.2% (range 10.3-64.6%). A simple Poisson regression model revealed no significant relationship between the percentage of patients with an ASA score of C3 and mortality. BMI and preoperative albumin level were reported, respectively, in 4 (8.7%) and 6 (13%) of the cohort, making any statistical analysis impractical.
Multiple Poisson Regression Models of Predictor Variables
Multiple Poisson regression analysis was performed to derive the independent effect of statistically significant predictor variables, identified in the simple models, on mortality rate. Because the report of severe complications was missing in the 76% of cohort, it was not tested in the multiple model. In multiple Poisson regression, both age and FIGO stage IV were significantly correlated with incidence rate for mortality. Each 1% increase in the proportion of patients with stage IV disease was associated with a 1.7% increase incidence rate of mortality (IRR 1.017; 95% CI 1.01-1.03). Each 1-year increase in median age was associated with an estimated 8 7% increase in the incidence rate for mortality rate (IRR 1.087; 95% CI 1.054-1.121). The estimated risk of perioperative mortality adjusted for different age and FIGO stage IV is reported in Table 4 .
DISCUSSION
Primary debulking surgery with the aim of leaving no residual tumor is still considered the standard surgical treatment for patients with advanced ovarian cancer. 3, 46 To reach such a goal, several different and difficult surgical procedures may be required. Significant surgical mortality is therefore associated with these complex procedures. The main purpose of the present study was to systematically review all studies including patients undergoing PDS and reporting surgical mortality. Our data suggest that the estimated 30-day mortality for primary debulking surgery is 4.64% (95% CI 4.58-4.69). Although not significant, perioperative mortality rates have progressively decreased in the most recent years, probably due to the advances in perioperative care, surgical procedures, and device technology. Considering the progressive decreasing trend of mortality over the years, the current mortality rate is probably lower than the one we estimated. A major finding of our analysis is the strong association between age and perioperative mortality. Each 1-year increase in median age was associated with an estimated 8.8% increase in the incidence rate for mortality. For example, adjusted for other variables and the absence of stage IV, the estimated mean perioperative mortality rate was 1.2% (95% CI 0.95-1.75) at median age 55 years and 2.8% (95% CI 2.02-3.66) at median age 65 years. This finding is consistent with the most recent literature but should be interpreted with caution. 5, 31, 42 Different authors have clearly demonstrated a benefit of complete cytoreduction in terms of survival, regardless of age. 5, 51 In fact, if on the one hand elderly patients are at increased risk of surgical morbidity and mortality, then on the other hand they could receive a survival benefit equivalent to that of younger women if they are able to tolerate aggressive surgical procedures. 42 The impact of mortality and morbidity appears to be strongly influenced by patients' comorbidities. 5 For this reason, age should not be considered a contraindication per se to highly complex surgery, but it should be evaluated in the overall assessment of the patient's medical condition. Excluding patients only on account of advanced age could deprive a considerable number of women the benefits of primary surgery, particularly those with an acceptable performance and nutritional status, in whom gross disease can reasonably be removed without many complex surgical procedures. This aspect is particularly important given the peak of incidence of ovarian cancer after the sixth decade of life and the progressive aging of worldwide population. Patient age should be an important factor in the decision-making process, as this review indicates. If many and complex surgical procedures are anticipated by the preoperative imaging assessment or at the beginning of the surgical assessment, alternative strategies may be reasonable. 4 Another major finding of our analysis is the strong association between frequency of stage IV disease and perioperative mortality. More than 70% of ovarian cancer patients are diagnosed with disease in an advanced stage, and the number of patients with stage IV disease is not negligible (the mean weighed frequency among all cohorts in the present analysis 25.69%; 95% CI 25.42-25.95). Even if the prognosis of patients with stage IV disease is markedly poor with rapidly progressive disease, complete surgical debulking appears to be an important determinant of survival in patients with stage IV disease as well. 19, 52, 53 In a series of stage IV ovarian cancer patients surgically treated with curative intent, 6% of the patients died within 30 days from the surgery. However, 80% of these patients had an ASA performance status of 3 and had significant comorbid conditions. 19 The reasons why FIGO stage IV disease appears to be independently associated with an increased incidence of perioperative mortality could be the overall impairment of the patient's conditions and associated to a more complex surgery required to allow complete cytoreduction. 54 In addition, the patients with stage IV ovarian cancer have the worst immunologic and nutritional condition. 52 Serum albumin is a well-established marker of nutritional status and general patient status and has been indicated as an independent prognostic predictor of morbidity and poor prognosis in patients with ovarian cancer. Moreover, a recent multicenter study identified a subgroup of patients [high tumor burden (including stage IV), age [75 years, and ASA C3 and/or preoperative albumin B3.0 g/dl] in which aggressive surgery carries increased morbidity without survival benefit. 4, 55 Our analysis indicates a correlation between advanced age or FIGO stage, and ASA score or preoperative albumin level (data not reported). However, these findings could not be considered as conclusive because of the small number of cohorts that reported the relevant clinical information for this comparison. Similar observations have also been confirmed in the literature. Among all the studies analyzed, the most frequently described cause of death after surgery was severe sepsis/ septic shock (Table 2 ). This finding is in line with recent evidence demonstrating that hypoalbuminemia is highly correlated with the incidence and the severity of sepsis in the postoperative period. 56 Moreover, nutritional status was also reported to be a strong predictor of anastomotic leak in the colorectal literature. 57 Pulmonary embolism was the second most described cause of postoperative death. The diagnosis of deep vein thrombosis and pulmonary embolism might be the first symptom of occult malignant disease, and it has been shown to significantly affect overall survival in patients with ovarian cancer. [58] [59] [60] [61] The incidence of pulmonary embolism is particularly high within the first 2 months after radical surgery. 61, 62 Even if deaths from a pulmonary embolism are usually preventable if patients are hospitalized, sometimes patients may die within 30 min from the occurrence of the first clinical symptoms.
The challenge of the decision making process for highrisk patients for primary surgery versus alternative strategies, including neoadjuvant or definitive chemotherapy, lies in the balance between an expected improved survival if complete debulking is achieved and the expected surgical morbidity and mortality. Current data are not available to allow accurate risk prediction of surgical mortality in ovarian cancer. One of the major strengths of the present study is the possibility to estimate the risk of postoperative mortality using two easy-to-obtain clinical parameters: age and FIGO stage IV. This tool can also be useful for counseling patients in order to minimize surgical risks and offer an alternative therapeutic option for patients at higher risk of perioperative mortality; for example, the estimated perioperative mortality risk in patients [75 years old at FIGO stage IV is 37.2% (95% CI 16.73-57.74) (Fig. 2) .
Both surgical complexity index and highest procedure complexity were positively associated with overall rate of complications, as expected. On the other hand, we identified a nonsignificant decreasing trend in postoperative mortality with an increase in surgical complexity. This finding seems to be consistent with the literature. 4, 63 However, these findings could also be influenced by the selection criteria for surgery in the different studies. Highly complex surgical procedures are usually reserved for patients with good performance status, who are able to tolerate such long operations. Recently several authors proposed different ways of measuring patients' increased vulnerability (frailty) resulting from aging-associated decline in reserve and function across multiple physiologic systems. These frailty scores are strongly correlated with the occurrence of postoperative morbidity and mortality. 63, 64 In a recent study in which a comprehensive, physical functioning, comorbidity, nutrition, cognition, and emotional assessment was measured, the fitness level of patients was better than chronological age as a predictor for postoperative morbidity. 65 These results demonstrate why a carefully preoperative evaluation of patients is crucial to selecting those who may benefit from extensive and aggressive surgery and should include evaluations of nutritional status, comorbidity, and patient frailty.
In conclusion, the results of the present metaregression clearly demonstrate that increased age and advanced clinical stage are independently associated with an increased risk of surgical mortality in patients undergoing primary debulking surgery for advanced ovarian cancer. The combined effect of both factors results in an exponential increase in the mortality rate. Combined information from these two variables could potentially serve as a proxy of the nutritional and performance status of the patients. Careful patient evaluations may help identify patients at higher risk of perioperative mortality for whom alternative therapeutic strategies may be recommended. 
APPENDIX
A quality score was used to evaluate whether any studies were useful for the purpose of our analysis. The quality score was calculated by summing the singular score assigned to each of following variables: Type of study (prospective = 2, retrospective, or population = 1), total number of patients per study (\50 = 1; 50-100 = 2; [100 = 3), volume of the center (number of patients per year of study: \10 = 1; 10-20 = 2; [20 = 3). All studies with quality score of \4 were excluded.
The weighted complexity index was calculated by summing the numbers of procedures of each cohort multiplied by the assigned score of each procedure divided by the number of patients in each cohort as shown in the following formula Eq. 
A score of 1, 2 or 3 was assigned to each procedure modified from Aletti et al. 4 The ''highest complexity procedure index'' was calculated by summing the numbers of highest complexity procedures of each cohort divided by the number of patients in each cohort, as shown in the following formula Eq. (2) 
